Avantax Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Avantax Advisory Services's JAZZ Position: Q2 2025 in Review
Avantax Advisory Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.8% in Q2 2025, selling an estimated $1.74K and leaving 1,974 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.
Avantax Advisory Services first reported a position in JAZZ in Q4 2024 and has held it in 3 quarters since. The position peaked at $264K in Q4 2024. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.
- Avantax Advisory Services held 1,974 shares of Jazz Pharmaceuticals worth $209K as of Q2 2025.
- Avantax Advisory Services sold 16 Jazz Pharmaceuticals shares in Q2 2025, an estimated $1.74K.
- Jazz Pharmaceuticals made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2171 holding.
- Avantax Advisory Services first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- Avantax Advisory Services's Jazz Pharmaceuticals position peaked at $264K in Q4 2024.
- 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.
Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.